Skip Navigation
Print This Page
Share this page: More

Stem Cell Therapy

With the promise of stem cell therapy to regenerate the damaged nervous systems of patients with neuromyelitis optica (NMO) and other diseases of the nervous system comes the problem of delivery.

Current research on delivery of stem cells focuses on numerous surgical transplants into lesioned sites of the central nervous system (CNS), but this approach is unrealistic in human patients given the large number and extent of lesions found in NMO patients over time.

A better approach would be to develop a regenerative stem cell that can be infused intravascularly and target the inflamed areas of the CNS. This approach would avoid risky surgeries and can easily be applied many times over the course of an NMO patient’s lifetime as necessary.


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.